X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2019 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
ALEMBIC PHARMA Fact Sheet, ALEMBIC PHARMA Financial Results - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ALEMBIC PHARMA Fact Sheet   (APLL)

Here is the latest financial fact sheet of ALEMBIC PHARMA. For more details, see the ALEMBIC PHARMA quarterly results and ALEMBIC PHARMA share price and chart. For a sector overview, read our pharmaceuticals sector report.

ALEMBIC PHARMA Price History

Price Rs 480.9
Mkt Cap Rs m 90,650
Vol '000 3.3
P/E X 15.3
P/CF X 12.8
EPS (TTM) Rs 31.4
% ch % -1.8
No. of shares m 188.52
% ch week % -4.2
% ch 1-mth % -9.2
% ch 12-mth % -5.7
52 week H/L Rs 664.0/478.0
(As on Jun 18, 2019 (Close))
* Results Consolidated
Excel EXPORT | DO YOU LIKE THESE FACTSHEETS? TELL US!

ALEMBIC PHARMA Financials

No. of Mths
Year Ending
12
Mar-15
*
12
Mar-16
*
12
Mar-17
*
12
Mar-18
*
12
Mar-19
*
5-Yr Chart
Click to enlarge
ALEMBIC PHARMA EQUITY SHARE DATA
High Rs495792709645664 
Low Rs228443516470412 
Sales per share (Unadj.) Rs109.1167.0166.3166.1208.7 
Earnings per share (Unadj.) Rs15.038.221.421.931.0 
Diluted earnings per shareRs15.038.221.421.931.0 
Cash flow per share (Unadj.) Rs17.442.025.827.537.1 
Dividends per share (Unadj.) Rs3.504.004.004.005.50 
Adj. dividends per shareRs3.504.004.004.005.50 
Dividend yield (eoy) %1.00.60.70.71.0 
Book value per share (Unadj.) Rs46.984.9100.9117.8144.2 
Adj. book value per shareRs46.984.9100.9117.8144.2 
Shares outstanding (eoy) m188.52188.52188.52188.52188.52 
Bonus/Rights/Conversions  ----- 
Price / Sales ratio x3.33.73.73.42.6 
Avg P/E ratio x24.116.228.625.517.4 
P/CF ratio (eoy) x20.814.723.820.314.5 
Price / Book Value ratio x7.77.36.14.73.7 
Dividend payout %23.310.518.718.317.7 
Avg Mkt Cap Rs m68,122116,383115,459105,090101,461 
No. of employees `000NANANANANA 
Total wages/salary Rs m3,0684,2145,5886,2287,467 
Avg. sales/employee Rs ThNMNMNMNMNM 
Avg. wages/employee Rs ThNMNMNMNMNM 
Avg. net profit/employee Rs ThNMNMNMNMNM 
ALEMBIC PHARMA INCOME DATA
Net Sales Rs m20,56131,48731,34631,30839,347 
Other income Rs m2355207094 
Total revenues Rs m20,58431,54231,36631,37839,441 
Gross profit Rs m4,03010,0606,1536,4318,736 
Depreciation Rs m4447228301,0551,152 
Interest Rs m18375234184 
Profit before tax Rs m3,5919,3565,2915,4137,493 
Minority Interest Rs m000011 
Prior Period Items Rs m2-2-38-81-93 
Extraordinary Inc (Exp) Rs m00000 
Tax Rs m7642,1601,2221,2041,568 
Profit after tax Rs m2,8297,1944,0314,1285,844 
Gross profit margin %19.631.919.620.522.2 
Effective tax rate %21.323.123.122.220.9 
Net profit margin %13.822.812.913.214.9 
ALEMBIC PHARMA BALANCE SHEET DATA
Current assets Rs m8,90715,06613,72518,24719,577 
Current liabilities Rs m6,8417,6746,92711,23514,896 
Net working cap to sales %10.123.521.722.411.9 
Current ratio x1.32.02.01.61.3 
Inventory Days Days6867748690 
Debtors Days Days6441396145 
Net fixed assets Rs m5,9478,23711,95720,03527,097 
Share capital Rs m377377377377377 
"Free" reserves Rs m8,37415,41618,64621,82426,811 
Net worth Rs m8,84616,00519,02322,20127,188 
Long term debt Rs m188005,0004,993 
Total assets Rs m16,41224,59426,89339,41147,778 
Interest coverage x202.7255.2102.2160.241.7 
Debt to equity ratio x0000.20.2 
Sales to assets ratio x1.31.31.20.80.8 
Return on assets %17.329.415.210.612.6 
Return on equity %32.044.921.218.621.5 
Return on capital %40.058.727.919.723.6 
Exports to sales %39.355.749.846.40 
Imports to sales %10.010.410.310.50 
Exports (fob) Rs m8,08517,55115,62614,5350 
Imports (cif) Rs m2,0503,2833,2413,2880 
Fx inflow Rs m8,28417,81115,80614,72219,453 
Fx outflow Rs m3,1475,3185,2897,0266,065 
Net fx Rs m5,13712,49310,5177,69613,388 
ALEMBIC PHARMA CASH FLOW
From Operations Rs m 1,718 9,304 3,286 3,124 8,120 
From Investments Rs m -2,556 -3,105 -4,859 -8,844 -7,556 
From Financial Activity Rs m 867 -1,959 -1,289 5,026 590 
Net Cashflow Rs m 29 4,240 -2,862 -693 1,153 
* Results Consolidated
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Share Holding

Indian Promoters 74.1%
Foreign collaborators 0.0%
Indian inst/Mut Fund 2.9%
FIIs 9.1%
ADR/GDR 0.0%
Free float 13.9%
Shareholders 49,328
Pledged promoter(s) holding 0.0%
 

Company Information

REGD OFF Alembic Road, ,Vadodara,Gujarat - 390 003
E-MAIL apl.investors@alembic.co.in WEB www.alembic-india.com
TELEPHONE (0265) 2282 550 FAX (0265) 2282 506
SECTOR PHARMACEUTICALS GROUP MISCELLANEOUS
TR AGENT Link Intime India, B-102-103, Shangrila Complex, Akota, Vadodara-20
AUDITOR K. S. Aiyar & Co.
CHM: Chirayu R. Amin (MD) COMP SEC: Rajkumar Baheti YEAR OF INC: 2010 BSE CODE: 533573 FV (Rs): 2 DIV YIELD (%): 1.1

Read: ALEMBIC PHARMA 2018-19 Annual Report Analysis

More Pharmaceuticals Company Fact Sheets:   WOCKHARDT  SUVEN LIFESCIENCES  ASTRAZENECA PHARMA  J.B.CHEMICALS  FDC LTD.  

Compare ALEMBIC PHARMA With:   WOCKHARDT  SUVEN LIFESCIENCES  ASTRAZENECA PHARMA  J.B.CHEMICALS  FDC LTD.  

Compare ALEMBIC PHARMA With:   ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  MYLAN (US)  TEVA PHARMA (Israel)  



Today's Market

Indian Indices End on a Positive Note; Oil & Gas and IT Stocks Witness Buying(Closing)

Indian share markets traded on a positive note most of the day and ended marginally higher. Gains were seen in the oil & gas sector and IT sector.

Views on news

ALEMBIC PHARMA 2018-19 Annual Report Analysis (Annual Result Update)

Jun 13, 2019 | Updated on Jun 13, 2019

Here's an analysis of the annual report of ALEMBIC PHARMA for 2018-19. It includes a full income statement, balance sheet and cash flow analysis of ALEMBIC PHARMA. Also includes updates on the valuation of ALEMBIC PHARMA.

ALEMBIC PHARMA Announces Quarterly Results (4QFY19); Net Profit Up 28.9% (Quarterly Result Update)

May 9, 2019 | Updated on May 9, 2019

For the quarter ended March 2019, ALEMBIC PHARMA has posted a net profit of Rs 1 bn (up 28.9% YoY). Sales on the other hand came in at Rs 9 bn (up 8.6% YoY). Read on for a complete analysis of ALEMBIC PHARMA's quarterly results.

ALEMBIC PHARMA 2017-18 Annual Report Analysis (Annual Result Update)

Dec 21, 2018 | Updated on Dec 21, 2018

Here's an analysis of the annual report of ALEMBIC PHARMA for 2017-18. It includes a full income statement, balance sheet and cash flow analysis of ALEMBIC PHARMA. Also includes updates on the valuation of ALEMBIC PHARMA.

ALEMBIC PHARMA Announces Quarterly Results (2QFY19); Net Profit Up 61.0% (Quarterly Result Update)

Oct 23, 2018 | Updated on Oct 23, 2018

For the quarter ended September 2018, ALEMBIC PHARMA has posted a net profit of Rs 2 bn (up 61.0% YoY). Sales on the other hand came in at Rs 11 bn (up 42.8% YoY). Read on for a complete analysis of ALEMBIC PHARMA's quarterly results.

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

More Views on News

Most Popular

7 Stocks That Will Remain Evergreen in this Era of Technological Disruption(The 5 Minute Wrapup)

Jun 13, 2019

We are living in an era of disruption. Are your stocks well equipped to adapt to changes that disruption will bring along?

The Great Indian NBFC Bubble Has Burst but I Will Still Recommend These Safe NBFCs(The 5 Minute Wrapup)

Jun 11, 2019

One chart that predicted the NBFC crisis back in 2016.

Just One Stock Made Buffett Billions - And Can Make You Crores(Profit Hunter)

Jun 6, 2019

Coca Cola is arguably one of Warren Buffet's best stock picks. But did you know that small investors picked up the stock five decades before Buffet? Read on...

Kenneth Andrade Would Like Our Real Estate Stock Recommendation with Triple Digit Upside(The 5 Minute Wrapup)

Jun 12, 2019

This real estate stock recommended in Smart Money Secrets offers the most favourable upside potential.

Why Modi 2.0 Will Be Great for These 7 Stocks(Profit Hunter)

Jun 10, 2019

The government's focus on Infra, electricity, water for all will be the key factors for Sensex 1,00,000.

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2019
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

TRACK ALEMBIC PHARMA

  • Track your investment in ALEMBIC PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON ALEMBIC PHARMA

ALEMBIC PHARMA - SUVEN LIFESCIENCES COMPARISON

COMPARE ALEMBIC PHARMA WITH

MARKET STATS